Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
International Journal of Breast Cancer is Scopus-indexed (Q2, CiteScore 4.2), WoS ESCI, DOAJ. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 2090-3170Verify ISSN ↗2090-3189Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 125 / 278 | 55th | Q2 |
| Oncology | 205 / 428 | 52nd | Q2 |
| Cancer Research | 152 / 233 | 34th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q2, CiteScore 4.2.
International Journal of Breast Cancer is Q2 in Pharmacology (medical) (rank 125 of 278), Q2 in Oncology (rank 205 of 428) and Q3 in Cancer Research (rank 152 of 233), by CiteScore 2025.
International Journal of Breast Cancer is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.2, which places it in quartile Q2 at the 55th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.585, quartile Q3, with an H-index of 27.
The publisher lists an article processing charge of about US$1,000 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
International Journal of Breast Cancer is published by John Wiley and Sons Ltd. Its print ISSN is 2090-3170 and its online ISSN is 2090-3189.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
International Journal of Breast Cancer has an h-index of 47 and a 2-year mean of 1.76 citations per paper (OpenAlex). Its Scopus CiteScore is 4.2, quartile Q2. On 2-year citations it ranks #143 of 271 Scopus journals in Pharmacology (medical).
International Journal of Breast Cancer published 25 papers in 2025; its busiest recent year was 2024 with 25. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2022–2026), authors are most often from Iran (16.2%), India (9.4%) and United States (7.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.